Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients

By Akbas S.H.   Yavuz A.   Tuncer M.   Yurdakonar E.   Akcit F.   Gurkan A.   Demirbas A.   Gultekin M.   Ersoy F.   Akaydin M.  

Transplantation Proceedings, Vol. 36, Iss. 1, 2004-01 ,pp. : 86-88

Elsevier

Access to resources Recommend Favorite

Analytical and clinical evaluation of the EMIT mycophenolic acid immunoassay in kidney transplantation

By Mourad M.   Chaib-Eddour D.   Malaise J.   Konig J.   Squifflet J.P.   Wallemacq P.E.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 404-406

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients

By Gaston R.   Alloway R.R.   Gaber A.O.   Rossi S.J.   Schroeder T.J.   Irish W.D.   Canafax D.M.   First M.R.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 326-327

Elsevier

Access to resources Recommend Favorite

Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients

By Hesse C.J.   Baan C.C.   Balk A.H.M.M.   Metselaar H.J.   Weimar W.   van Gelder T.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2988-2990

Elsevier

Access to resources Recommend Favorite

The Beneficial Effects of Anisodamine for CyA Hepatotoxicity in the Rat and in Renal-Transplant Recipients

By Wang X.   Tang X.   Xie T.   Sun X.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 286-287

Elsevier

Access to resources Recommend Favorite